文献速递前列腺癌

多参数磁共振/超声融合前列腺穿刺:每个磁共振病灶仅需2针?

Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
PubMed 文献 · J Urol · 2018-05-05

该研究回顾性分析418例患者共1064个前列腺病灶的2128条穿刺针芯,评估每个磁共振病灶仅取1针的可行性。结果显示首针检出89%的前列腺癌,但首针漏诊的21例中9例Gleason评分为6分,且首针阳性者中10%经第二针升级Gleason评分。结论认为每病灶超过1针仅轻微提高检出率和分级准确性。

要点

  • 每个磁共振病灶首针可检出89%的前列腺癌。
  • 首针漏诊的21例前列腺癌中9例(43%)Gleason评分为6分。
  • 首针阳性者中10%经第二针升级Gleason评分。

核心结论

  • 每个磁共振病灶获取超过1条穿刺针芯仅轻微提高前列腺癌检出率和Gleason分级准确性。

研究设计与样本

  • 回顾性评估418例患者共1064个前列腺病灶的2128条穿刺针芯(每病灶2针),比较第一针与第二针的组织学和Gleason评分。

主要发现

  • 总体前列腺癌检出率为45.7%(191/418例)。
  • 第一针检出191例前列腺癌中的170例(89%)。
  • 第一针检出的170例前列腺癌中,17例(10%)经第二针升级Gleason评分。
  • 第一针漏诊的21例前列腺癌中,9例(43%)Gleason评分为6分。
  • 2128条针芯中537条阳性,第一针283条(26.6%),第二针254条(24%)(p≤0.001)。

临床怎么用

  • 在融合穿刺中,每个磁共振病灶取1针可能足以检出多数前列腺癌,但需权衡漏诊和Gleason升级风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: For multiparametric magnetic resonance imaging/ultrasound fusion prostate biopsy the number of biopsy cores obtained is arbitrarily established by urologists. Moreover, a general consensus is lacking on the number of biopsy cores to be obtained from a single magnetic resonance imaging lesion. Therefore, we evaluated the feasibility of obtaining only 1 biopsy core per magnetic resonance imaging lesion. MATERIALS AND METHODS: We retrospectively evaluated a total of 2,128 biopsy cores of 1,064 prostatic lesions (2 cores per lesion) in 418 patients in regard to prostate cancer detection (histology) and the Gleason score of the first biopsy core compared to the second biopsy core. Two analyses were performed, including patient level analysis based on prostate cancer detection per patient and lesion level analysis based exclusively on the histology of each lesion regardless of the overall histological outcome of the case. RESULTS: The overall prostate cancer detection rate was 45.7% (191 of 418 patients). The first biopsy core detected 170 of all 191 prostate cancers (89%). In 17 of these 170 prostate cancers (10%) the second biopsy core revealed Gleason score upgrading. Nine of the 21 prostate cancers (43%) missed by the first biopsy core had a Gleason score of 6. Altogether 537 of the 2,128 biopsy cores were positive, including 283 first (26.6%) and 254 second (24%) biopsy cores (p ≤0.001). The concordance between the first and second biopsy cores was 89% (κ = 0.71). There was a discrepancy with Gleason score upgrading in 28 of 212 lesions (13.2%) with positive first and second biopsy cores. CONCLUSIONS: Our study shows that obtaining more than 1 biopsy core per magnetic resonance imaging lesion only slightly improves the prostate cancer detection rate and Gleason grading.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Dimitroulis P, Rabenalt R, Nini A, et al. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required? J Urol. 2018. PMID: 29733837. doi:10.1016/j.juro.2018.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。